Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection

Avibactam is a new non-β-lactam β-lactamase inhibitor that shows promising restoration of ceftazidime activity against microorganisms producing Ambler class A extended-spectrum β-lactamases (ESBLs) and carbapenemases such as KPCs, class C β-lactamases (AmpC), and some class D enzymes. To determine o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Berkhout, Johanna, Melchers, Maria J., van Mil, Anita C., Seyedmousavi, Seyedmojtaba, Lagarde, Claudia M., Schuck, Virna J., Nichols, Wright W., Mouton, Johan W.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2015
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704241/
https://ncbi.nlm.nih.gov/pubmed/26525790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01269-15
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires